Advisory Research Inc Johnson & Johnson Transaction History

Advisory Research Inc

$499 Million
Q2 2024

A detailed history of Advisory Research Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Advisory Research Inc holds 5,559 shares of JNJ stock, worth $916,234. This represents 0.16% of its overall portfolio holdings.

Number of Shares

5,559

Previous 4,906 13.31%

Holding current value

$916,234

Previous $776,000 4.64%

% of portfolio

0.16%

Previous 0.16%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $94,280 - $103,030	653 Added 13.31%	5,559 $812,000
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $42,530 - $44,590	-274 Reduced 5.29%	4,906 $776,000
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $506,396 - $552,584	-3,478 Reduced 40.17%	5,180 $811,000
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $276,300 - $309,527	-1,774 Reduced 17.01%	8,658 $1.35 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $106,038 - $114,117	687 Added 7.05%	10,432 $1.73 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $1,963 - $2,343	13 Added 0.13%	9,745 $1.51 Million
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $17,301 - $19,417	-108 Reduced 1.1%	9,732 $1.72 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $20,972 - $23,337	-130 Reduced 1.3%	9,840 $1.61 Million
Q2 2022 Aug 17, 2022	BUY	$168.19 - $186.01 $504 - $558	3 Added 0.03%	9,970 $1.77 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $41,748 - $47,411	264 Added 2.72%	9,967 $1.77 Million
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $17.5 Million - $19.4 Million	-112,259 Reduced 92.04%	9,703 $1.66 Million
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $5.9 Million - $6.55 Million	36,508 Added 42.72%	121,962 $19.7 Million
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $25,835 - $27,713	-162 Reduced 0.19%	85,454 $14.1 Million
Q1 2021 May 12, 2021	SELL	$153.07 - $170.48 $449,719 - $500,870	-2,938 Reduced 3.32%	85,616 $14.1 Million
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $923,984 - $1.06 Million	-6,739 Reduced 7.07%	88,554 $13.9 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $2.09 Million - $2.29 Million	-14,903 Reduced 13.52%	95,293 $14.2 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $16.7 Million - $20.1 Million	-129,295 Reduced 53.99%	110,196 $15.5 Million
Q1 2020 May 12, 2020	BUY	$111.14 - $153.99 $364,205 - $504,625	3,277 Added 1.39%	239,491 $31.4 Million
Q4 2019 Feb 11, 2020	SELL	$127.5 - $146.44 $1.31 Million - $1.51 Million	-10,290 Reduced 4.17%	236,214 $34.5 Million
Q3 2019 Nov 12, 2019	BUY	$126.95 - $142.14 $51,033 - $57,140	402 Added 0.16%	246,504 $31.9 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $311,087 - $342,137	-2,372 Reduced 0.95%	246,102 $34.3 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $201,403 - $223,943	1,602 Added 0.65%	248,474 $34.7 Million
Q4 2018 Feb 13, 2019	BUY	$122.84 - $147.84 $14.7 Million - $17.7 Million	119,923 Added 94.47%	246,872 $31.9 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $1.13 Million - $1.32 Million	-9,271 Reduced 6.81%	126,949 $17.5 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $29.5 Million - $32.6 Million	-247,294 Reduced 64.48%	136,220 $16.5 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $748,348 - $886,173	5,982 Added 1.58%	383,514 $49.1 Million
Q4 2017 Feb 08, 2018	BUY	$131.22 - $143.62 $694,416 - $760,037	5,292 Added 1.42%	377,532 $52.7 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $48.2 Million - $50.4 Million	372,240	372,240 $48.4 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.

Account

Advisory Research Inc Johnson & Johnson Transaction History